« European Initiative Targets Diagnosis, Treatment of Rare Diseases » article has just been released on ALS NEWS Today! Check it out! <<A new international consortium based in Paris, and funded largely by the 28-member European Union, intends to speed the diagnosis of rare diseases, while also accelerating the development of treatments for the 95% of such…
Representatives from paediatric networks, research infrastructures (RIs), European Reference Networks (ERNs), charities, patients’ associations, Young Persons Advisory Groups (YPAGs), companies’ federations, Governments and regulatory Authorities had a very productive discussion during the stakeholders roundtable held in the framework of the 3rd General Assembly of EPTRI (European Paediatric Translational Research Infrastructure) in Madrid, Spain, on March…
The European Union has invested heavily in health research. Since the early 2000’s it supported the creation of European Research Infrastructures (pan-European organisations devoted to health research) like BBMRI, EATRIS, ECRIN, ELIXIR, and funded the Innovative Medicines Initiative (IMI), the world’s largest public private partnership (PPP) in health. The combination of PPPs such as the IMI and European infrastructures…
The rare disease international film festival is the first and only film festival on rare diseases in Europe. It collects and promotes the best video works on rare diseases and social inclusion through an international competition and works with public and private partners, both national and international, the rare diseases community, disability advocates, entertainment and…
On September 16th 2019, a workshop “Rare disease perspectives in Central – Eastern Europe”, twinned to the General Assembly of EJP RD, will be organized in Gdansk, Poland. The main aims of this conference are discuss challenges and opportunities of rare disease research in Central – Eastern Europe countries and areas of involvement within EJP…
EMA’s human medicines committee (CHMP) has recommended the authorisation of Palynziq (pegvaliase), a new medicine for patients aged 16 and older with phenylketonuria, a rare but potentially serious inherited metabolic disease. Patients suffering from this disorder do not have the enzyme that breaks down phenylalanine, an amino acid which is found in most foods containing…
A new EURORDIS-led article, « Share and protect our health data: an evidence based approach to rare disease patients’ perspectives on data sharing and data protection – quantitative survey and recommendations » has just been published in the Orphanet Journal of Rare Diseases. The peer-reviewed article is freely accessed, it was written in collaboration with Rebecca Dimond,…
New Frontier Research – Health article by Horizon Magazine on a video at nanometre resolution -first time ever-, where scientists filmed how the immune system kills bacteria by poking holes into it. Professor Georg Fantner tells about how this was achieved and why his next challenge is to build a video camera that can film…
The success of European research missions, which aim to stimulate innovation to solve major societal problems, will require a complete change in the way governments think about business and risk, according to Professor Mariana Mazzucato, special advisor to the European Commissioner for Research, Science and Innovation, Carlos Moedas. On 4 July 2019, Prof. Mazzucato published a report…
A call for application for the preparation of EPTRI feasibility studies has been launched.Feasibility studies are aimed to test the process, the scientific interest, the availability of requested services and facilities needed to conduct paediatric research in the areas of EPTRI competence. Check it out!